Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
What People Get Wrong About Retirement Planning
Identifying common mistakes in retirement planning can save you from future pitfalls. Learn what to avoid for a secure retirement.
14,327 articles
Rhode Island Senate Will Vote on Faith-Based Housing Bill
The Rhode Island Senate is poised to vote on a faith-based affordable housing bill, a key step in a long-running hous...
Clariti Studio Launches to Help Cities Cut Permitting Delays
Clariti unveils Clariti AI Studio, a free training program for local governments aiming to speed up permitting. The i...
Brown Brown (BRO) 2026 Outlook: BRO Q1 Earnings
This article breaks down BRO's Q1 2026 earnings, highlights the key drivers behind growth, and offers practical steps...
MoonLake Immunotherapeutics Trims Stake: Investor Watch
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
Poor Man’s 1031 Exchange Emerges in Real Estate Loans
In 2026, a calendar-year depreciation tactic is drawing interest from small investors who want to offset gains from p...
Precigen (PGEN) Stock Sell: Should You Dump After CFO Sale?
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Citi, Ford, Experian Share AI-Scaling Playbooks for 2026
Citi, Ford, and Experian unveil scalable AI agent playbooks that emphasize governance and visibility as they push AI ...
Should You Sell If Slide Insurance Chief Risk Sells Stock?
When a top executive sells stock, it sparks questions about the company’s prospects. This guide breaks down insider m...
McGraw Hill Buys 22,000 Shares: Is This Bullish for MH Investors?
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
What $722,000 TransMedics Insider Sale Signals Investors
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
Anthropic’s Mythos Model Cleared Boosts AI Access Markets
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status